| abstract |
This application discloses compounds of generic Formula I':or pharmaceutically acceptable salts thereof, wherein A, Q, X, Y, Z 1 , Z 2 , m, p, q, z, R 1 , R 1' , R 2 , R 3 and R 4 are defined as described herein, useful for treatment of diseases associated with monoamine deficiency. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the compounds. |